世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い



世界の植物と植物由来薬品市場予測 2017-2025年

GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET FORECAST 2017-2025

 

出版社 出版日電子媒体価格ページ数
Inkwood Research
インクウッドリサーチ
2017年10月 US$ 2,500
シングルユーザライセンス
145p

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートは世界の植物と植物由来薬品市場を分析・予測したInkwood Researchの市場調査報告書です。

Description

KEY FINDINGS
The global botanical and plant derivative drug market was calculated to be worth $ 37865 million in 2016. The market is projected to grow with a CAGR of 3.53% over the forecast period of 2017-2025, generating $51881 million by the end of 2025.
MARKET INSIGHTS
The global market for botanical and plant-derived drugs is chiefly driven by their growing applications in diseases and the technological advancements in their manufacturing processes. The market is segmented on the basis of products, therapeutic applications, and derivative drug type. The products from these market include Herbal/traditional topical analgesics, pediatric dietary supplements, tonics and herbal/traditional remedies for a cough, cold and allergy (hay fever), digestive remedies and dermatological remedies. The market finds its application in areas like dermatology, hormone diseases, CNS disorders, oncology, etc. The botanical and plant derivative drug types include steroids, terpenes, glycosides, phenols, etc.
REGIONAL INSIGHTS
The global botanical and plant-derivative drug market is geographically segmented into regions of North America, Europe, Asia-Pacific and rest of the world. The Asia-Pacific market is predicted to account for the highest share of the global market by the end of the forecast period. This growth can be attributed to the rising demand for plant derivative drugs from the APAC countries. These countries report a high number of cases for infectious as well as respiratory diseases. In order to treat these diseases, the plant-based derivatives drugs are increasingly being preferred.

COMPETITIVE INSIGHTS
Pfizer and Abbott are two of the leading pharmaceutical companies that deal in botanical, and plant-derived drug markets. Some of the other key players competing in the global market include Bayer Healthcare Llc, Bristol-Myers Squibb, Bionova, Cura Pharm, GlaxoSmithKline, Eli Lilly And Company, Glenmark Pharmaceuticals Ltd, Medigene, Lupin Ltd, Novartis International Ag, Ranbaxy Laboratories Ltd (Acquired By Sun Pharmaceuticals Ltd), Piramal Phytocare Ltd., and Tasly Pharmaceuticals Inc.


目次

Table of Contents

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. ASIA PACIFIC LEADS THE GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET
3.2.2. INDIAN BOTANICAL AND PLANT DERIVATIVE DRUGS MARKET TO OFFER GREAT OPPORTUNITIES
3.2.3. GLYCOSIDES MARKET IS QUICKLY RISING IN TERMS OF TYPES
3.2.4. ONCOLOGY HOLDS THE LARGEST MARKET SHARE IN TERMS OF THERAPEUTIC APPLICATION
3.2.5. HERBAL/TRADITIONAL TOPICAL ANALGESICS PRODUCT IS GROWING RAPIDLY
4. MARKET DYNAMICS
4.1. DRIVERS
4.1.1. GROWING APPLICATIONS IN DISEASES
4.1.2. GROWING FDA APPROVALS
4.1.3. TECHNOLOGICAL DEVELOPMENT IN MANUFACTURING PROCESSES
4.1.4. RISING DEMAND FOR TRADITIONAL MEDICINES
4.1.5. GROWING FOCUS TOWARDS NATURAL SOURCE MEDICINES
4.2. RESTRAINTS
4.2.1. STRINGENT REGULATIONS REGARDING THE USE AND APPROVAL OF BOTANICAL DRUGS
4.2.2. LIMITED ADOPTION OF BOTANICAL AND PLANT DERIVATIVE DRUGS
4.3. OPPORTUNITIES
4.3.1. RISING FDA APPROVALS FOR BOTANICAL DRUGS
4.3.2. INCREASING ADOPTION OF BOTANICAL DRUGS
4.3.3. INCREASING INVESTMENT IN ASIA PACIFIC REGION
4.4. CHALLENGES
4.4.1. PRESENCE OF SUBSTITUTES FOR BOTANICAL & PLANT DERIVATIVE DRUG
4.4.2. TOXICITY RELATED ISSUES AND SAFETY CONCERNS
5. MARKET SEGMENTATION
5.1. MARKET BY TYPES 2017-2025
5.1.1. TERPENES
5.1.2. STEROIDS
5.1.3. GLYCOSIDES
5.1.4. PHENOLS
5.1.5. OTHER TYPES
5.2. MARKET BY THERAPEUTIC APPLICATIONS 2017-2025
5.2.1. ONCOLOGY
5.2.2. DERMATOLOGY
5.2.3. CNS DISORDERS
5.2.4. HORMONE DISEASES
5.2.5. OTHER THERAPEUTIC APPLICATIONS
5.3. MARKET BY PRODUCTS 2017-2025
5.3.1. HERBAL/TRADITIONAL TOPICAL ANALGESICS
5.3.2. HERBAL/TRADITIONAL COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES
5.3.3. HERBAL/TRADITIONAL DIGESTIVE REMEDIES
5.3.4. HERBAL/TRADITIONAL DERMATOLOGICAL
5.3.5. HERBAL/TRADITIONAL PEDIATRIC DIETARY SUPPLEMENTS
5.3.6. HERBAL/TRADITIONAL DIETARY SUPPLEMENTS
5.3.7. HERBAL/TRADITIONAL TONICS
6. KEY ANALYTICS
6.1. MANUFACTURING PROCESS
6.2. VALUE CHAIN ANALYSIS
6.3. LEGAL, POLICY AND REGULATORY FRAMEWORK
6.4. PORTER’S FIVE FORCES ANALYSIS
6.4.1. THREAT OF NEW ENTRANTS
6.4.2. THREATS OF SUBSTITUTE PRODUCT
6.4.3. BARGAINING POWER OF BUYER
6.4.4. BARGAINING POWER OF SUPPLIER
6.4.5. INTENSITY OF COMPETITIVE RIVALRY
6.5. KEY BUYING CRITERIA
7. GEOGRAPHIC ANALYSIS
7.1. NORTH AMERICA
7.1.1. UNITED STATES
7.1.2. CANADA
7.2. EUROPE
7.2.1. UNITED KINGDOM
7.2.2. FRANCE
7.2.3. GERMANY
7.2.4. SPAIN
7.2.5. ITALY
7.2.6. REST OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. CHINA
7.3.2. INDIA
7.3.3. JAPAN
7.3.4. AUSTRALIA
7.3.5. SOUTH KOREA
7.3.6. REST OF ASIA-PACIFIC
7.4. REST OF WORLD
7.4.1. LATIN AMERICA
7.4.2. MIDDLE EAST & AFRICA
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIES
8.1.1. MERGER & ACQUISITION
8.1.2. PARTNERSHIP & COLLABORATION
8.1.3. EXPANSION & INVESTMENT
8.2. MARKET SHARE ANALYSIS
8.3. KEY COMPANIES ANALYSIS
9. COMPANY PROFILE
9.1. ABBOTT LABORATORIES
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. STRATEGIC INITIATIVES
9.1.4. SCOT ANALYSIS
9.2. BAYER HEALTHCARE LLC
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. SCOT ANALYSIS
9.3. BIONOVA
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. SCOT ANALYSIS
9.4. BRISTOL-MYERS SQUIBB
9.4.1. OVERVIEW
9.4.2. STRATEGIC INITIATIVE
9.4.3. SCOT ANALYSIS
9.5. CURA PHARM
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. SCOT ANALYSIS
9.6. ELI LILLY AND COMPANY
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. SCOT ANALYSIS
9.7. GLAXOSMITHKLINE
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. STRATEGIC INITIATIVES
9.7.4. SCOT ANALYSIS
9.8. GLENMARK PHARMACEUTICALS LTD.
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. STRATEGIC INITIATIVE
9.8.4. SCOT ANALYSIS
9.9. LUPIN LTD
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVE
9.9.4. SCOT ANALYSIS
9.10. MEDIGENE
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. STRATEGIC INITIATIVES
9.10.4. SCOT ANALYSIS
9.11. NOVARTIS INTERNATIONAL AG
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVES
9.11.4. SCOT ANALYSIS
9.12. PFIZER
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. STRATEGIC INITIATIVE
9.12.4. SCOT ANALYSIS
9.13. PIRAMAL PHYTOCARE LTD.
9.13.1. OVERVIEW
9.13.2. PRODUCT PORTFOLIO
9.13.3. STRATEGIC INITIATIVE
9.13.4. SCOT ANALYSIS
9.14. RANBAXY LABORATORIES LTD (ACQUIRED BY SUN PHARMACEUTICALS LTD)
9.14.1. OVERVIEW
9.14.2. PRODUCTION PORTFOLIO
9.14.3. STRATEGIC INITIATIVE
9.14.4. SCOT ANALYSIS
9.15. TASLY PHARMACEUTICALS INC.
9.15.1. OVERVIEW
9.15.2. PRODUCTION PORTFOLIO
9.15.3. SCOT ANALYSIS
?

TABLE LIST
TABLE 1 GLOBAL BOTANICAL & PLANT DERIVATIVE DRUG MARKET, BY GEOGRAPHY2017-2025 ($ MILLION)
TABLE 2 GLOBAL BOTANICAL & PLANT DERIVATIVE DRUG MARKET, BY TYPES 2017-2025 ($ MILLION)
TABLE 3 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN TERPENES, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 4 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN STEROIDS BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 5 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN GLYCOSIDES, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 6 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN PHENOLS, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 7 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHER TYPES 2017-2025 ($ MILLION)
TABLE 8 GLOBAL BOTANICAL & PLANT DERIVATIVE DRUG MARKET BY THERAPEUTIC APPLICATIONS 2017-2025 ($ MILLION)
TABLE 9 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN ONCOLOGY, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 10 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN DERMATOLOGY, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 11 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN CNS DISORDERS, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 12 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHERS THERAPEUTIC APPLICATIONS BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 13 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET, BY PRODUCT 2017-2025 ($ MILLION)
TABLE 14 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TOPICAL ANALGESICS, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 15 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET FOR HERBAL/TRADITIONAL COUGH, COLD, AND ALLERGY (HAY FEVER) REMEDIES, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 16 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIGESTIVE REMEDIES, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 17 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DERMATOLOGICALS, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 18 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL PAEDIATRIC DIETARY SUPPLEMENTS, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 19 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIETARY SUPPLEMENTS, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 20 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TONICS, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 21 GLOBAL BOTANICAL & PLANT DERIVATIVE DRUG MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 22 NORTH AMERICA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
TABLE 23 EUROPE BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
TABLE 24 ASIA-PACIFIC BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
TABLE 25 REST OF WORLD BOTANICAL AND PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)


FIGURE LIST
FIGURE 1 ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 2 INDIA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 3 GLOBAL BOTANICAL & PLANT DERIVATIVE DRUG MARKET IN GLYCOSIDES 2017-2025 ($ MILLION)
FIGURE 4 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN TERPENES 2017-2025 ($ MILLION)
FIGURE 5 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN STEROIDS 2017-2025 ($ MILLION)
FIGURE 6 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN GLYCOSIDES 2017-2025 ($ MILLION)
FIGURE 7 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN PHENOLS 2017-2025 ($ MILLION)
FIGURE 8 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHER TYPES 2017-2025 ($ MILLION)
FIGURE 9 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN ONCOLOGY 2017-2025 ($ MILLION)
FIGURE 10 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN DERMATOLOGY 2017-2025 ($ MILLION)
FIGURE 11 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN CNS DISORDERS 2017-2025 ($ MILLION)
FIGURE 12 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HORMONE DISEASE 2017-2025 ($ MILLION)
FIGURE 13 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HORMONE DISEASE, BY GEOGRAPHY 2017-2025 ($ MILLION)
FIGURE 14 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHERS THERAPEUTIC APPLICATIONS 2017-2025 ($ MILLION)
FIGURE 15 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TOPICAL ANALGESICS 2017-2025 ($ MILLION)
FIGURE 16 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET FOR HERBAL/TRADITIONAL COUGH, COLD, AND ALLERGY (HAY FEVER) REMEDIES 2017-2025 ($ MILLION)
FIGURE 17 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIGESTIVE REMEDIES 2017-2025 ($ MILLION)
FIGURE 18 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DERMATOLOGICALS 2017-2025 ($ MILLION)
FIGURE 19 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL PAEDIATRIC DIETARY SUPPLEMENTS 2017-2025 ($ MILLION)
FIGURE 20 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIETARY SUPPLEMENTS 2017-2025 ($ MILLION)
FIGURE 21 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TONICS 2017-2025 ($ MILLION)
FIGURE 22 EVOLUTION OF BOTANICAL AND PLANT DERIVATIVE DRUGS
FIGURE 23 NORTH AMERICA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 24 UNITED STATES BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 25 CANADA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 26 UK BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 27 FRANCE BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 28 GERMANY BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 29 SPAIN BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 30 ITALY BOTANICAL PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 31 REST OF EUROPE BOTANICAL &PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 32 CHINA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 33 INDIA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 34 JAPAN BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 35 AUSTRALIA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 36 SOUTH KOREA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 37 REST OF ASIA PACIFIC BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 38 LATIN AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 39 MIDDLE EAST & AFRICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 40 GLOBAL BOTANICAL & PLANT DERIVATIVE DRUG MARKET SHARE 2016

List of Tables

TABLE LIST
TABLE 1 GLOBAL BOTANICAL & PLANT DERIVATIVE DRUG MARKET, BY GEOGRAPHY2017-2025 ($ MILLION)
TABLE 2 GLOBAL BOTANICAL & PLANT DERIVATIVE DRUG MARKET, BY TYPES 2017-2025 ($ MILLION)
TABLE 3 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN TERPENES, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 4 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN STEROIDS BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 5 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN GLYCOSIDES, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 6 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN PHENOLS, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 7 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHER TYPES 2017-2025 ($ MILLION)
TABLE 8 GLOBAL BOTANICAL & PLANT DERIVATIVE DRUG MARKET BY THERAPEUTIC APPLICATIONS 2017-2025 ($ MILLION)
TABLE 9 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN ONCOLOGY, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 10 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN DERMATOLOGY, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 11 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN CNS DISORDERS, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 12 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHERS THERAPEUTIC APPLICATIONS BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 13 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET, BY PRODUCT 2017-2025 ($ MILLION)
TABLE 14 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TOPICAL ANALGESICS, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 15 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET FOR HERBAL/TRADITIONAL COUGH, COLD, AND ALLERGY (HAY FEVER) REMEDIES, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 16 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIGESTIVE REMEDIES, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 17 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DERMATOLOGICALS, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 18 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL PAEDIATRIC DIETARY SUPPLEMENTS, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 19 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIETARY SUPPLEMENTS, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 20 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TONICS, BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 21 GLOBAL BOTANICAL & PLANT DERIVATIVE DRUG MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 22 NORTH AMERICA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
TABLE 23 EUROPE BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
TABLE 24 ASIA-PACIFIC BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
TABLE 25 REST OF WORLD BOTANICAL AND PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)

List of Figures

FIGURE LIST
FIGURE 1 ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 2 INDIA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 3 GLOBAL BOTANICAL & PLANT DERIVATIVE DRUG MARKET IN GLYCOSIDES 2017-2025 ($ MILLION)
FIGURE 4 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN TERPENES 2017-2025 ($ MILLION)
FIGURE 5 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN STEROIDS 2017-2025 ($ MILLION)
FIGURE 6 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN GLYCOSIDES 2017-2025 ($ MILLION)
FIGURE 7 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN PHENOLS 2017-2025 ($ MILLION)
FIGURE 8 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHER TYPES 2017-2025 ($ MILLION)
FIGURE 9 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN ONCOLOGY 2017-2025 ($ MILLION)
FIGURE 10 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN DERMATOLOGY 2017-2025 ($ MILLION)
FIGURE 11 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN CNS DISORDERS 2017-2025 ($ MILLION)
FIGURE 12 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HORMONE DISEASE 2017-2025 ($ MILLION)
FIGURE 13 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HORMONE DISEASE, BY GEOGRAPHY 2017-2025 ($ MILLION)
FIGURE 14 GLOBAL BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHERS THERAPEUTIC APPLICATIONS 2017-2025 ($ MILLION)
FIGURE 15 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TOPICAL ANALGESICS 2017-2025 ($ MILLION)
FIGURE 16 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET FOR HERBAL/TRADITIONAL COUGH, COLD, AND ALLERGY (HAY FEVER) REMEDIES 2017-2025 ($ MILLION)
FIGURE 17 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIGESTIVE REMEDIES 2017-2025 ($ MILLION)
FIGURE 18 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DERMATOLOGICALS 2017-2025 ($ MILLION)
FIGURE 19 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL PAEDIATRIC DIETARY SUPPLEMENTS 2017-2025 ($ MILLION)
FIGURE 20 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIETARY SUPPLEMENTS 2017-2025 ($ MILLION)
FIGURE 21 GLOBAL BOTANICAL AND DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TONICS 2017-2025 ($ MILLION)
FIGURE 22 EVOLUTION OF BOTANICAL AND PLANT DERIVATIVE DRUGS
FIGURE 23 NORTH AMERICA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 24 UNITED STATES BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 25 CANADA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 26 UK BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 27 FRANCE BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 28 GERMANY BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 29 SPAIN BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 30 ITALY BOTANICAL PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 31 REST OF EUROPE BOTANICAL &PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 32 CHINA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 33 INDIA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 34 JAPAN BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 35 AUSTRALIA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 36 SOUTH KOREA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 37 REST OF ASIA PACIFIC BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 38 LATIN AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 39 MIDDLE EAST & AFRICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET 2017-2025 ($ MILLION)
FIGURE 40 GLOBAL BOTANICAL & PLANT DERIVATIVE DRUG MARKET SHARE 2016

 

COPYRIGHT(C) 2011-2019 DATA RESOURCES, Inc. ALL RIGHTS RESERVED.